Global Electroporated Competent Cells Market Growth 2026-2032

October 2026 | 123 pages | ID: GB81FAD3C59CEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Electroporated Competent Cells market size is predicted to grow from US$ 1514 million in 2025 to US$ 2412 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.

Electroporated Competent Cells refer to laboratory-prepared microbial cells with enhanced membrane permeability and transformation capability, specifically optimized for introducing external genetic materials through electroporation technology. The products are mainly used for molecular cloning, recombinant DNA construction, synthetic biology, protein expression and genetic engineering research.

Electroporation competent cells are commonly derived from bacterial strains such as Escherichia coli and are engineered or optimized to achieve high transformation efficiency, low background contamination and reliable experimental performance. Key performance parameters include transformation efficiency, genotype stability, antibiotic resistance selection compatibility and storage stability.

The market scope includes commercially available electrocompetent cells supplied as research reagents. Chemically competent cells, complete cloning kits, plasmid DNA products, sequencing services and laboratory services are excluded.

In 2025, the global average selling price is approximately US$180 per vial, sales volume is approximately 8.60 million vials, and the estimated average manufacturer gross margin is approximately 52%.The upstream segment mainly includes microbial strains, culture media components, cryoprotectants, enzymes, molecular biology reagents, laboratory consumables and bioprocessing equipment.

The midstream segment covers strain selection, cell cultivation, competency preparation, electroporation optimization, quality testing, aliquoting, cryopreservation and reagent packaging.

The downstream segment mainly includes universities, research institutes, biotechnology companies, pharmaceutical companies, agricultural biotechnology companies and molecular biology laboratories using genetic engineering technologies.

Electrocompetent cells are essential tools in modern molecular biology workflows due to their ability to achieve high-efficiency DNA transformation. Increasing research activity in synthetic biology, genome engineering and recombinant protein production continues to support demand growth.

Product development is mainly focused on improving transformation efficiency, expanding compatible host strains and enhancing batch-to-batch consistency. High-performance competent cells are increasingly designed for difficult-to-transform plasmids, large DNA constructs and advanced genetic engineering applications.

The growth of biotechnology research, pharmaceutical development and academic molecular biology programs is expanding the application base of electrocompetent cells. Customized strains with specialized characteristics are also creating additional market opportunities.

Future market growth will be supported by increasing genetic engineering activities, expansion of biotechnology applications and continued innovation in laboratory workflows.

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “Electroporated Competent Cells Industry Forecast” looks at past sales and reviews total world Electroporated Competent Cells sales in 2025, providing a comprehensive analysis by region and market sector of projected Electroporated Competent Cells sales for 2026 through 2032. With Electroporated Competent Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Electroporated Competent Cells industry.

This Insight Report provides a comprehensive analysis of the global Electroporated Competent Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Electroporated Competent Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Electroporated Competent Cells market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Electroporated Competent Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Electroporated Competent Cells.

This report presents a comprehensive overview, market shares, and growth opportunities of Electroporated Competent Cells market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

  • Efficient Electroporated Competent Cells
  • Ordinary Electroporated Competent Cells

Segmentation by Host Strain:

  • E. coli Electrocompetent Cells
  • Yeast Electrocompetent Cells
  • Other Microbial Electrocompetent Cells

Segmentation by Product Format:

  • Frozen Liquid Cells
  • Ready-to-Use Aliquoted Cells
  • Custom Prepared Competent Cells

Segmentation by Application:

  • Pharmaceutical Companies
  • Lab
  • Others

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Takara Bio Inc.
  • Agilent Technologies, Inc.
  • New England Biolabs, Inc.
  • Promega Corporation
  • Lucigen Corporation
  • Zymo Research Corporation
  • Bio-Rad Laboratories, Inc.
  • GeneScript Biotech Corporation
  • TransGen Biotech Co., Ltd.
  • Yeasen Biotechnology Co., Ltd.
  • Vazyme Biotech Co., Ltd.

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Electroporated Competent Cells market?
  • What factors are driving Electroporated Competent Cells market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Electroporated Competent Cells market opportunities vary by end market size?
  • How does Electroporated Competent Cells break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Electroporated Competent Cells Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Electroporated Competent Cells by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Electroporated Competent Cells by Country/Region, 2021, 2025 & 2032
2.2 Electroporated Competent Cells Segment by Type
  2.2.1 Efficient Electroporated Competent Cells
  2.2.2 Ordinary Electroporated Competent Cells
  2.2.3 Electroporated Competent Cells Sales by Type
    2.2.3.1 Global Electroporated Competent Cells Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Electroporated Competent Cells Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Electroporated Competent Cells Sale Price by Type (2021-2026)
2.3 Electroporated Competent Cells Segment by Host Strain
  2.3.1 E. coli Electrocompetent Cells
  2.3.2 Yeast Electrocompetent Cells
  2.3.3 Other Microbial Electrocompetent Cells
  2.3.4 Electroporated Competent Cells Sales by Host Strain
    2.3.4.1 Global Electroporated Competent Cells Sales Market Share by Host Strain (2021-2026)
    2.3.4.2 Global Electroporated Competent Cells Revenue and Market Share by Host Strain (2021-2026)
    2.3.4.3 Global Electroporated Competent Cells Sale Price by Host Strain (2021-2026)
2.4 Electroporated Competent Cells Segment by Product Format
  2.4.1 Frozen Liquid Cells
  2.4.2 Ready-to-Use Aliquoted Cells
  2.4.3 Custom Prepared Competent Cells
  2.4.4 Electroporated Competent Cells Sales by Product Format
    2.4.4.1 Global Electroporated Competent Cells Sales Market Share by Product Format (2021-2026)
    2.4.4.2 Global Electroporated Competent Cells Revenue and Market Share by Product Format (2021-2026)
    2.4.4.3 Global Electroporated Competent Cells Sale Price by Product Format (2021-2026)
2.5 Electroporated Competent Cells Segment by Application
  2.5.1 Pharmaceutical Companies
  2.5.2 Lab
  2.5.3 Others
  2.5.4 Electroporated Competent Cells Sales by Application
    2.5.4.1 Global Electroporated Competent Cells Sale Market Share by Application (2021-2026)
    2.5.4.2 Global Electroporated Competent Cells Revenue and Market Share by Application (2021-2026)
    2.5.4.3 Global Electroporated Competent Cells Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Electroporated Competent Cells Breakdown Data by Company
  3.1.1 Global Electroporated Competent Cells Annual Sales by Company (2021-2026)
  3.1.2 Global Electroporated Competent Cells Sales Market Share by Company (2021-2026)
3.2 Global Electroporated Competent Cells Annual Revenue by Company (2021-2026)
  3.2.1 Global Electroporated Competent Cells Revenue by Company (2021-2026)
  3.2.2 Global Electroporated Competent Cells Revenue Market Share by Company (2021-2026)
3.3 Global Electroporated Competent Cells Sale Price by Company
3.4 Key Manufacturers Electroporated Competent Cells Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Electroporated Competent Cells Product Location Distribution
  3.4.2 Players Electroporated Competent Cells Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ELECTROPORATED COMPETENT CELLS BY GEOGRAPHIC REGION

4.1 World Historic Electroporated Competent Cells Market Size by Geographic Region (2021-2026)
  4.1.1 Global Electroporated Competent Cells Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Electroporated Competent Cells Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Electroporated Competent Cells Market Size by Country/Region (2021-2026)
  4.2.1 Global Electroporated Competent Cells Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Electroporated Competent Cells Annual Revenue by Country/Region (2021-2026)
4.3 Americas Electroporated Competent Cells Sales Growth
4.4 APAC Electroporated Competent Cells Sales Growth
4.5 Europe Electroporated Competent Cells Sales Growth
4.6 Middle East & Africa Electroporated Competent Cells Sales Growth

5 AMERICAS

5.1 Americas Electroporated Competent Cells Sales by Country
  5.1.1 Americas Electroporated Competent Cells Sales by Country (2021-2026)
  5.1.2 Americas Electroporated Competent Cells Revenue by Country (2021-2026)
5.2 Americas Electroporated Competent Cells Sales by Type (2021-2026)
5.3 Americas Electroporated Competent Cells Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Electroporated Competent Cells Sales by Region
  6.1.1 APAC Electroporated Competent Cells Sales by Region (2021-2026)
  6.1.2 APAC Electroporated Competent Cells Revenue by Region (2021-2026)
6.2 APAC Electroporated Competent Cells Sales by Type (2021-2026)
6.3 APAC Electroporated Competent Cells Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Electroporated Competent Cells by Country
  7.1.1 Europe Electroporated Competent Cells Sales by Country (2021-2026)
  7.1.2 Europe Electroporated Competent Cells Revenue by Country (2021-2026)
7.2 Europe Electroporated Competent Cells Sales by Type (2021-2026)
7.3 Europe Electroporated Competent Cells Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Electroporated Competent Cells by Country
  8.1.1 Middle East & Africa Electroporated Competent Cells Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Electroporated Competent Cells Revenue by Country (2021-2026)
8.2 Middle East & Africa Electroporated Competent Cells Sales by Type (2021-2026)
8.3 Middle East & Africa Electroporated Competent Cells Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Electroporated Competent Cells
10.3 Manufacturing Process Analysis of Electroporated Competent Cells
10.4 Industry Chain Structure of Electroporated Competent Cells

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Electroporated Competent Cells Distributors
11.3 Electroporated Competent Cells Customer

12 WORLD FORECAST REVIEW FOR ELECTROPORATED COMPETENT CELLS BY GEOGRAPHIC REGION

12.1 Global Electroporated Competent Cells Market Size Forecast by Region
  12.1.1 Global Electroporated Competent Cells Forecast by Region (2027-2032)
  12.1.2 Global Electroporated Competent Cells Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Electroporated Competent Cells Forecast by Type (2027-2032)
12.7 Global Electroporated Competent Cells Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Thermo Fisher Scientific Inc.
  13.1.1 Thermo Fisher Scientific Inc. Company Information
  13.1.2 Thermo Fisher Scientific Inc. Electroporated Competent Cells Product Portfolios and Specifications
  13.1.3 Thermo Fisher Scientific Inc. Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Thermo Fisher Scientific Inc. Main Business Overview
  13.1.5 Thermo Fisher Scientific Inc. Latest Developments
13.2 Merck KGaA
  13.2.1 Merck KGaA Company Information
  13.2.2 Merck KGaA Electroporated Competent Cells Product Portfolios and Specifications
  13.2.3 Merck KGaA Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Merck KGaA Main Business Overview
  13.2.5 Merck KGaA Latest Developments
13.3 Takara Bio Inc.
  13.3.1 Takara Bio Inc. Company Information
  13.3.2 Takara Bio Inc. Electroporated Competent Cells Product Portfolios and Specifications
  13.3.3 Takara Bio Inc. Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Takara Bio Inc. Main Business Overview
  13.3.5 Takara Bio Inc. Latest Developments
13.4 Agilent Technologies, Inc.
  13.4.1 Agilent Technologies, Inc. Company Information
  13.4.2 Agilent Technologies, Inc. Electroporated Competent Cells Product Portfolios and Specifications
  13.4.3 Agilent Technologies, Inc. Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Agilent Technologies, Inc. Main Business Overview
  13.4.5 Agilent Technologies, Inc. Latest Developments
13.5 New England Biolabs, Inc.
  13.5.1 New England Biolabs, Inc. Company Information
  13.5.2 New England Biolabs, Inc. Electroporated Competent Cells Product Portfolios and Specifications
  13.5.3 New England Biolabs, Inc. Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 New England Biolabs, Inc. Main Business Overview
  13.5.5 New England Biolabs, Inc. Latest Developments
13.6 Promega Corporation
  13.6.1 Promega Corporation Company Information
  13.6.2 Promega Corporation Electroporated Competent Cells Product Portfolios and Specifications
  13.6.3 Promega Corporation Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Promega Corporation Main Business Overview
  13.6.5 Promega Corporation Latest Developments
13.7 Lucigen Corporation
  13.7.1 Lucigen Corporation Company Information
  13.7.2 Lucigen Corporation Electroporated Competent Cells Product Portfolios and Specifications
  13.7.3 Lucigen Corporation Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Lucigen Corporation Main Business Overview
  13.7.5 Lucigen Corporation Latest Developments
13.8 Zymo Research Corporation
  13.8.1 Zymo Research Corporation Company Information
  13.8.2 Zymo Research Corporation Electroporated Competent Cells Product Portfolios and Specifications
  13.8.3 Zymo Research Corporation Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Zymo Research Corporation Main Business Overview
  13.8.5 Zymo Research Corporation Latest Developments
13.9 Bio-Rad Laboratories, Inc.
  13.9.1 Bio-Rad Laboratories, Inc. Company Information
  13.9.2 Bio-Rad Laboratories, Inc. Electroporated Competent Cells Product Portfolios and Specifications
  13.9.3 Bio-Rad Laboratories, Inc. Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Bio-Rad Laboratories, Inc. Main Business Overview
  13.9.5 Bio-Rad Laboratories, Inc. Latest Developments
13.10 GeneScript Biotech Corporation
  13.10.1 GeneScript Biotech Corporation Company Information
  13.10.2 GeneScript Biotech Corporation Electroporated Competent Cells Product Portfolios and Specifications
  13.10.3 GeneScript Biotech Corporation Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 GeneScript Biotech Corporation Main Business Overview
  13.10.5 GeneScript Biotech Corporation Latest Developments
13.11 TransGen Biotech Co., Ltd.
  13.11.1 TransGen Biotech Co., Ltd. Company Information
  13.11.2 TransGen Biotech Co., Ltd. Electroporated Competent Cells Product Portfolios and Specifications
  13.11.3 TransGen Biotech Co., Ltd. Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 TransGen Biotech Co., Ltd. Main Business Overview
  13.11.5 TransGen Biotech Co., Ltd. Latest Developments
13.12 Yeasen Biotechnology Co., Ltd.
  13.12.1 Yeasen Biotechnology Co., Ltd. Company Information
  13.12.2 Yeasen Biotechnology Co., Ltd. Electroporated Competent Cells Product Portfolios and Specifications
  13.12.3 Yeasen Biotechnology Co., Ltd. Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Yeasen Biotechnology Co., Ltd. Main Business Overview
  13.12.5 Yeasen Biotechnology Co., Ltd. Latest Developments
13.13 Vazyme Biotech Co., Ltd.
  13.13.1 Vazyme Biotech Co., Ltd. Company Information
  13.13.2 Vazyme Biotech Co., Ltd. Electroporated Competent Cells Product Portfolios and Specifications
  13.13.3 Vazyme Biotech Co., Ltd. Electroporated Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Vazyme Biotech Co., Ltd. Main Business Overview
  13.13.5 Vazyme Biotech Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Electroporated Competent Cells Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Electroporated Competent Cells Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Efficient Electroporated Competent Cells
Table 4. Major Players of Ordinary Electroporated Competent Cells
Table 5. Global Electroporated Competent Cells Sales by Type (2021-2026) & (Million Vials)
Table 6. Global Electroporated Competent Cells Sales Market Share by Type (2021-2026)
Table 7. Global Electroporated Competent Cells Revenue by Type (2021-2026) & ($ million)
Table 8. Global Electroporated Competent Cells Revenue Market Share by Type (2021-2026)
Table 9. Global Electroporated Competent Cells Sale Price by Type (2021-2026) & (US$/Vial)
Table 10. Major Players of E. coli Electrocompetent Cells
Table 11. Major Players of Yeast Electrocompetent Cells
Table 12. Major Players of Other Microbial Electrocompetent Cells
Table 13. Global Electroporated Competent Cells Sales by Host Strain (2021-2026) & (Million Vials)
Table 14. Global Electroporated Competent Cells Sales Market Share by Host Strain (2021-2026)
Table 15. Global Electroporated Competent Cells Revenue by Host Strain (2021-2026) & ($ million)
Table 16. Global Electroporated Competent Cells Revenue Market Share by Host Strain (2021-2026)
Table 17. Global Electroporated Competent Cells Sale Price by Host Strain (2021-2026) & (US$/Vial)
Table 18. Major Players of Frozen Liquid Cells
Table 19. Major Players of Ready-to-Use Aliquoted Cells
Table 20. Major Players of Custom Prepared Competent Cells
Table 21. Global Electroporated Competent Cells Sales by Product Format (2021-2026) & (Million Vials)
Table 22. Global Electroporated Competent Cells Sales Market Share by Product Format (2021-2026)
Table 23. Global Electroporated Competent Cells Revenue by Product Format (2021-2026) & ($ million)
Table 24. Global Electroporated Competent Cells Revenue Market Share by Product Format (2021-2026)
Table 25. Global Electroporated Competent Cells Sale Price by Product Format (2021-2026) & (US$/Vial)
Table 26. Global Electroporated Competent Cells Sale by Application (2021-2026) & (Million Vials)
Table 27. Global Electroporated Competent Cells Sale Market Share by Application (2021-2026)
Table 28. Global Electroporated Competent Cells Revenue by Application (2021-2026) & ($ million)
Table 29. Global Electroporated Competent Cells Revenue Market Share by Application (2021-2026)
Table 30. Global Electroporated Competent Cells Sale Price by Application (2021-2026) & (US$/Vial)
Table 31. Global Electroporated Competent Cells Sales by Company (2021-2026) & (Million Vials)
Table 32. Global Electroporated Competent Cells Sales Market Share by Company (2021-2026)
Table 33. Global Electroporated Competent Cells Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Electroporated Competent Cells Revenue Market Share by Company (2021-2026)
Table 35. Global Electroporated Competent Cells Sale Price by Company (2021-2026) & (US$/Vial)
Table 36. Key Manufacturers Electroporated Competent Cells Producing Area Distribution and Sales Area
Table 37. Players Electroporated Competent Cells Products Offered
Table 38. Electroporated Competent Cells Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Electroporated Competent Cells Sales by Geographic Region (2021-2026) & (Million Vials)
Table 42. Global Electroporated Competent Cells Sales Market Share Geographic Region (2021-2026)
Table 43. Global Electroporated Competent Cells Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Electroporated Competent Cells Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Electroporated Competent Cells Sales by Country/Region (2021-2026) & (Million Vials)
Table 46. Global Electroporated Competent Cells Sales Market Share by Country/Region (2021-2026)
Table 47. Global Electroporated Competent Cells Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Electroporated Competent Cells Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Electroporated Competent Cells Sales by Country (2021-2026) & (Million Vials)
Table 50. Americas Electroporated Competent Cells Sales Market Share by Country (2021-2026)
Table 51. Americas Electroporated Competent Cells Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Electroporated Competent Cells Sales by Type (2021-2026) & (Million Vials)
Table 53. Americas Electroporated Competent Cells Sales by Application (2021-2026) & (Million Vials)
Table 54. APAC Electroporated Competent Cells Sales by Region (2021-2026) & (Million Vials)
Table 55. APAC Electroporated Competent Cells Sales Market Share by Region (2021-2026)
Table 56. APAC Electroporated Competent Cells Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Electroporated Competent Cells Sales by Type (2021-2026) & (Million Vials)
Table 58. APAC Electroporated Competent Cells Sales by Application (2021-2026) & (Million Vials)
Table 59. Europe Electroporated Competent Cells Sales by Country (2021-2026) & (Million Vials)
Table 60. Europe Electroporated Competent Cells Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Electroporated Competent Cells Sales by Type (2021-2026) & (Million Vials)
Table 62. Europe Electroporated Competent Cells Sales by Application (2021-2026) & (Million Vials)
Table 63. Middle East & Africa Electroporated Competent Cells Sales by Country (2021-2026) & (Million Vials)
Table 64. Middle East & Africa Electroporated Competent Cells Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Electroporated Competent Cells Sales by Type (2021-2026) & (Million Vials)
Table 66. Middle East & Africa Electroporated Competent Cells Sales by Application (2021-2026) & (Million Vials)
Table 67. Key Market Drivers & Growth Opportunities of Electroporated Competent Cells
Table 68. Key Market Challenges & Risks of Electroporated Competent Cells
Table 69. Key Industry Trends of Electroporated Competent Cells
Table 70. Electroporated Competent Cells Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Electroporated Competent Cells Distributors List
Table 73. Electroporated Competent Cells Customer List
Table 74. Global Electroporated Competent Cells Sales Forecast by Region (2027-2032) & (Million Vials)
Table 75. Global Electroporated Competent Cells Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Electroporated Competent Cells Sales Forecast by Country (2027-2032) & (Million Vials)
Table 77. Americas Electroporated Competent Cells Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Electroporated Competent Cells Sales Forecast by Region (2027-2032) & (Million Vials)
Table 79. APAC Electroporated Competent Cells Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Electroporated Competent Cells Sales Forecast by Country (2027-2032) & (Million Vials)
Table 81. Europe Electroporated Competent Cells Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Electroporated Competent Cells Sales Forecast by Country (2027-2032) & (Million Vials)
Table 83. Middle East & Africa Electroporated Competent Cells Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Electroporated Competent Cells Sales Forecast by Type (2027-2032) & (Million Vials)
Table 85. Global Electroporated Competent Cells Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Electroporated Competent Cells Sales Forecast by Application (2027-2032) & (Million Vials)
Table 87. Global Electroporated Competent Cells Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Thermo Fisher Scientific Inc. Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 89. Thermo Fisher Scientific Inc. Electroporated Competent Cells Product Portfolios and Specifications
Table 90. Thermo Fisher Scientific Inc. Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 91. Thermo Fisher Scientific Inc. Main Business
Table 92. Thermo Fisher Scientific Inc. Latest Developments
Table 93. Merck KGaA Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck KGaA Electroporated Competent Cells Product Portfolios and Specifications
Table 95. Merck KGaA Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 96. Merck KGaA Main Business
Table 97. Merck KGaA Latest Developments
Table 98. Takara Bio Inc. Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 99. Takara Bio Inc. Electroporated Competent Cells Product Portfolios and Specifications
Table 100. Takara Bio Inc. Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 101. Takara Bio Inc. Main Business
Table 102. Takara Bio Inc. Latest Developments
Table 103. Agilent Technologies, Inc. Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 104. Agilent Technologies, Inc. Electroporated Competent Cells Product Portfolios and Specifications
Table 105. Agilent Technologies, Inc. Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 106. Agilent Technologies, Inc. Main Business
Table 107. Agilent Technologies, Inc. Latest Developments
Table 108. New England Biolabs, Inc. Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 109. New England Biolabs, Inc. Electroporated Competent Cells Product Portfolios and Specifications
Table 110. New England Biolabs, Inc. Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 111. New England Biolabs, Inc. Main Business
Table 112. New England Biolabs, Inc. Latest Developments
Table 113. Promega Corporation Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 114. Promega Corporation Electroporated Competent Cells Product Portfolios and Specifications
Table 115. Promega Corporation Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 116. Promega Corporation Main Business
Table 117. Promega Corporation Latest Developments
Table 118. Lucigen Corporation Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 119. Lucigen Corporation Electroporated Competent Cells Product Portfolios and Specifications
Table 120. Lucigen Corporation Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 121. Lucigen Corporation Main Business
Table 122. Lucigen Corporation Latest Developments
Table 123. Zymo Research Corporation Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 124. Zymo Research Corporation Electroporated Competent Cells Product Portfolios and Specifications
Table 125. Zymo Research Corporation Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 126. Zymo Research Corporation Main Business
Table 127. Zymo Research Corporation Latest Developments
Table 128. Bio-Rad Laboratories, Inc. Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 129. Bio-Rad Laboratories, Inc. Electroporated Competent Cells Product Portfolios and Specifications
Table 130. Bio-Rad Laboratories, Inc. Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 131. Bio-Rad Laboratories, Inc. Main Business
Table 132. Bio-Rad Laboratories, Inc. Latest Developments
Table 133. GeneScript Biotech Corporation Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 134. GeneScript Biotech Corporation Electroporated Competent Cells Product Portfolios and Specifications
Table 135. GeneScript Biotech Corporation Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 136. GeneScript Biotech Corporation Main Business
Table 137. GeneScript Biotech Corporation Latest Developments
Table 138. TransGen Biotech Co., Ltd. Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 139. TransGen Biotech Co., Ltd. Electroporated Competent Cells Product Portfolios and Specifications
Table 140. TransGen Biotech Co., Ltd. Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 141. TransGen Biotech Co., Ltd. Main Business
Table 142. TransGen Biotech Co., Ltd. Latest Developments
Table 143. Yeasen Biotechnology Co., Ltd. Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 144. Yeasen Biotechnology Co., Ltd. Electroporated Competent Cells Product Portfolios and Specifications
Table 145. Yeasen Biotechnology Co., Ltd. Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 146. Yeasen Biotechnology Co., Ltd. Main Business
Table 147. Yeasen Biotechnology Co., Ltd. Latest Developments
Table 148. Vazyme Biotech Co., Ltd. Basic Information, Electroporated Competent Cells Manufacturing Base, Sales Area and Its Competitors
Table 149. Vazyme Biotech Co., Ltd. Electroporated Competent Cells Product Portfolios and Specifications
Table 150. Vazyme Biotech Co., Ltd. Electroporated Competent Cells Sales (Million Vials), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2021-2026)
Table 151. Vazyme Biotech Co., Ltd. Main Business
Table 152. Vazyme Biotech Co., Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Electroporated Competent Cells
Figure 2. Electroporated Competent Cells Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Electroporated Competent Cells Sales Growth Rate 2021-2032 (Million Vials)
Figure 7. Global Electroporated Competent Cells Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Electroporated Competent Cells Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Electroporated Competent Cells Sales Market Share by Country/Region (2025)
Figure 10. Electroporated Competent Cells Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Efficient Electroporated Competent Cells
Figure 12. Product Picture of Ordinary Electroporated Competent Cells
Figure 13. Global Electroporated Competent Cells Sales Market Share by Type in 2026
Figure 14. Global Electroporated Competent Cells Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of E. coli Electrocompetent Cells
Figure 16. Product Picture of Yeast Electrocompetent Cells
Figure 17. Product Picture of Other Microbial Electrocompetent Cells
Figure 18. Global Electroporated Competent Cells Sales Market Share by Host Strain in 2026
Figure 19. Global Electroporated Competent Cells Revenue Market Share by Host Strain (2021-2026)
Figure 20. Product Picture of Frozen Liquid Cells
Figure 21. Product Picture of Ready-to-Use Aliquoted Cells
Figure 22. Product Picture of Custom Prepared Competent Cells
Figure 23. Global Electroporated Competent Cells Sales Market Share by Product Format in 2026
Figure 24. Global Electroporated Competent Cells Revenue Market Share by Product Format (2021-2026)
Figure 25. Electroporated Competent Cells Consumed in Pharmaceutical Companies
Figure 26. Global Electroporated Competent Cells Market: Pharmaceutical Companies (2021-2026) & (Million Vials)
Figure 27. Electroporated Competent Cells Consumed in Lab
Figure 28. Global Electroporated Competent Cells Market: Lab (2021-2026) & (Million Vials)
Figure 29. Electroporated Competent Cells Consumed in Others
Figure 30. Global Electroporated Competent Cells Market: Others (2021-2026) & (Million Vials)
Figure 31. Global Electroporated Competent Cells Sale Market Share by Application (2025)
Figure 32. Global Electroporated Competent Cells Revenue Market Share by Application in 2025
Figure 33. Electroporated Competent Cells Sales by Company in 2025 (Million Vials)
Figure 34. Global Electroporated Competent Cells Sales Market Share by Company in 2025
Figure 35. Electroporated Competent Cells Revenue by Company in 2025 ($ millions)
Figure 36. Global Electroporated Competent Cells Revenue Market Share by Company in 2025
Figure 37. Global Electroporated Competent Cells Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Electroporated Competent Cells Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Electroporated Competent Cells Sales 2021-2026 (Million Vials)
Figure 40. Americas Electroporated Competent Cells Revenue 2021-2026 ($ millions)
Figure 41. APAC Electroporated Competent Cells Sales 2021-2026 (Million Vials)
Figure 42. APAC Electroporated Competent Cells Revenue 2021-2026 ($ millions)
Figure 43. Europe Electroporated Competent Cells Sales 2021-2026 (Million Vials)
Figure 44. Europe Electroporated Competent Cells Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Electroporated Competent Cells Sales 2021-2026 (Million Vials)
Figure 46. Middle East & Africa Electroporated Competent Cells Revenue 2021-2026 ($ millions)
Figure 47. Americas Electroporated Competent Cells Sales Market Share by Country in 2025
Figure 48. Americas Electroporated Competent Cells Revenue Market Share by Country (2021-2026)
Figure 49. Americas Electroporated Competent Cells Sales Market Share by Type (2021-2026)
Figure 50. Americas Electroporated Competent Cells Sales Market Share by Application (2021-2026)
Figure 51. United States Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Electroporated Competent Cells Sales Market Share by Region in 2025
Figure 56. APAC Electroporated Competent Cells Revenue Market Share by Region (2021-2026)
Figure 57. APAC Electroporated Competent Cells Sales Market Share by Type (2021-2026)
Figure 58. APAC Electroporated Competent Cells Sales Market Share by Application (2021-2026)
Figure 59. China Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 63. India Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Electroporated Competent Cells Sales Market Share by Country in 2025
Figure 67. Europe Electroporated Competent Cells Revenue Market Share by Country (2021-2026)
Figure 68. Europe Electroporated Competent Cells Sales Market Share by Type (2021-2026)
Figure 69. Europe Electroporated Competent Cells Sales Market Share by Application (2021-2026)
Figure 70. Germany Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 71. France Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Electroporated Competent Cells Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Electroporated Competent Cells Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Electroporated Competent Cells Sales Market Share by Application (2021-2026)
Figure 78. Egypt Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Electroporated Competent Cells Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Electroporated Competent Cells in 2026
Figure 84. Manufacturing Process Analysis of Electroporated Competent Cells
Figure 85. Industry Chain Structure of Electroporated Competent Cells
Figure 86. Channels of Distribution
Figure 87. Global Electroporated Competent Cells Sales Market Forecast by Region (2027-2032)
Figure 88. Global Electroporated Competent Cells Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Electroporated Competent Cells Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Electroporated Competent Cells Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Electroporated Competent Cells Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Electroporated Competent Cells Revenue Market Share Forecast by Application (2027-2032)